Skip to main content
. 2025 Jul 9;17(14):2284. doi: 10.3390/cancers17142284
ADR Adverse Drug Reactions
ALT Alternative Lengthening of Telomeres
ATM Ataxia–Telangiectasia Mutated
ATR Ataxia–Telangiectasia And Rad3-Related Kinases:
ATRX Alpha Thalassemia/Mental Retardation Syndrome X-Linked
BER Base Excision Repair
BIR Break-Induced Replication
BLM Bloom Syndrome Protein
BRCA Adverse Drug Reactions
CAF Cancer-Associated Fibroblasts
CST complex Ctc1–Stn1–Ten1 Complex
DAXX Death Domain-Associated Protein
DDR Dna Damage Response
DNA-PK Dna-Dependent Protein Kinase
DR Direct Repair
DSB Double-Strand Break
EBV Epstein-Barr Virus
ecDNA Extrachromosomal Dna
EEC Endometrioid Endometrial Cancer
EGCG Epigallocatechin Gallate
FVYL Conserved Hydrophobic Pocket (Phenylalanine/Valine/Tyrosine/Leucine)
GnRHR Gonadotropin-Releasing Hormone Receptor
HGSOC High-Grade Serous Ovarian Cancer
HL Hodgkin Lymphoma
HR Homologous Recombination
hTERT Human Telomerase Reverse Transcriptase
hTR Human Telomerase
MMEJ Microhomology-Mediated End-Joining
MMR Mismatch Repair
MRN Mre11–Rad50–Nbs1 Protein Complex
NER Nucleotide Excision Repair
NHEJ Non-Homologous End Joining
NSCLC Non-Small Cell Lung Cancer
OvC Ovarian Cancer
POT1 Protection of Telomeres 1
RAP1 Repressor/Activator Protein 1
RP2D Recommended Phase 2 Dose
RPA Replication Protein A
SSA Single-Strand Annealing
TERC Human Telomerase Rna
TERT Telomerase Reverse Transcriptase
TIL Tumor-Infiltrating Lymphocytes
TIN2 Trf-Interacting Nuclear Protein 2
TL Telomere Length
TPP1 Tripeptidyl-Peptidase 1
TRF1 Telomeric Repeat-Binding Factor 1
TRF2 Telomeric Repeat-Binding Factor 2